Featured News

The ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.

With your help, we have invested significant resources into changing that reality in Washington, DC, and we are beginning to see a return on that investment.

The Senate Appropriations Committee has released their FY2021 funding recommendations, which includes report language directing NIH to support celiac disease research.

A new intensive study confirms that people with celiac disease are frequently exposed to gluten in food.

Researchers from Takeda Pharmaceuticals and the Celiac Disease Foundation presented a study which concluded that despite gluten-free diet adherence, many patients with celiac disease still have symptoms that substantially impact their lives.

A study led by Columbia University and Celiac Disease Foundation researchers examined probiotic use among celiac disease patients and was an Outstanding Poster Presenter recipient at the 2020 ACG Annual Scientific Meeting.

The following study, which examines the prevalence of dermatitis herpetiformis (DH), was made possible by the Foundation’s iCureCeliac® patient registry.

Dr. Samuel Gee was the first researcher to recognize that the symptoms of celiac disease could be treated through diet. Today, we celebrate Celiac Disease Awareness Day on Dr. Gee's birthday and remember how far we've come in celiac disease knowledge and research, while recognizing there is still a critical need for treatments and a cure.

Today, the U.S. Food and Drug Administration issued a final rule for gluten-free labeling compliance requirements for fermented and hydrolyzed foods.